Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Kilic E, Dietz GPH, Hermann DM, Baehr M (2002) Intravenous TAT-Bcl-XL is protective after middle cerebral artery occlusion in mice. Ann Neurol 52: 617–622
Michiue H, Tomizawa K, Wei F-Y, Matsushita M, Lu Y-F, Ichikawa T, Tamiya T, Date I, Matsui H (2005) The NH2 terminus of influenza virus hemagglutinin-2 subunit peptides enhances the antitumor potency of polyarginine-mediated p53 protein transduction. J Biol Chem 280(9): 8285–8289
Inoue M, Tomizawa K, Matsushita M, Lu Y-F, Yokoyama T, Yanai H, Takashima A, Kumon H, Matsui H (2006) p53 Protein transduction therapy: successful targeting and inhibition of the growth of the bladder cancer cells. Eur Urol 49: 161–168
Matsui H, Tomizawa K, Lu YF, Matsushita M (2003) Protein therapy: in vivo protein transduction by polyarginine (11R) PTD and subcellular targeting delivery. Curr Protein Pept Sci 4(2): 151–157
Matsushita M, Noguchi H, Lu YF, Tomizawa K, Michiue H, Li ST, Hirose K, Bonner-Weir S, Matsui H (2004) Photo-acceleration of protein release from endosome in the protein transduction system. FEBS Let 572(1–3): 221–226
Matsushita M, Tomizawa K, Moriwaki A, Li ST, Terada H, Matsui H (2001) A high-efficiency protein transduction system demonstrating the role of PKA in long-lasting long-term potentiation. J Neurosci 21(16): 6000–6007
McGirt MJ, Lynch JR, Parra A, Sheng H, Pearlstein RD, Laskowitz DT, Pelligrino DA, Warner DS (2002) Simvastatin increases endothelial nitric oxide synthase and ameliorates cerebral vasospasm resulting from subarachnoid hemorrhage. Stroke 33(12): 2950–2956
Onoue H, Tsutsui M, Smith L, Stelter A, O’Brien T, Katusic ZS (1998) Expression and function of recombinant endothelial nitric oxide synthase gene in canine basilar artery after experimental subarachnoid hemorrhage. Stroke 29(9): 1959–1965
Schwarze SR, Ho A, Vocero-Akbani A, Dowdy SF (1999) In vivo protein transduction: delivery of a biologically active protein into the mouse. Science 285(5433): 1569–1572
Schwarze SR, Hruska KA, Dowdy SF (2000) Protein transduction: unrestricted delivery into all cells? Trends Cell Biol 10(7): 290–295 (Review)
Takenobu T, Tomizawa K, Matsushita M, Li ST, Moriwaki A, Lu YF, Matsui H (2002) Development of p53 protein transduction therapy using membrane-permeable peptides and the application to oral cancer cells. Mol Cancer Ther 1: 1043–1049
Tsutsui M, Onoue H, Iida Y, Smith L, O’Brien T, Katusic ZS (1999) Adventitia-dependent relaxations of canine basilar arteries transduced with recombinant eNOS gene. 1: Am J Physiol 276(6 Pt 2): H1846–H1852
Kilic Ü, Kilic E, Dietz GPH, Bähr M (2003) Intravenous TAT-GDNF is protective after focal cerebral ischemia in mice. Stroke 34: 1304–1310
Verma IM, Somia N (1997) Gene therapy-promises, problems and prospects. Nature (Lond) 389: 239–242
Khurana VG, Smith LA, Baker TA, Eguchi D, O’Brien T, Katusic ZS (2002) Protective vasomotor effects of in vivo recombinant endothelial nitric oxide synthase gene expression in a canine model of cerebral vasospasm. Stroke 33(3): 782–789
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer-Verlag
About this paper
Cite this paper
Ogawa, T. et al. (2008). Endothelial nitric oxide synthase-11R protein therapy for prevention of cerebral vasospasm in rats: a preliminary report. In: Kırış, T., Zhang, J.H. (eds) Cerebral Vasospasm. Acta Neurochirurgica Supplement, vol 104. Springer, Vienna. https://doi.org/10.1007/978-3-211-75718-5_32
Download citation
DOI: https://doi.org/10.1007/978-3-211-75718-5_32
Published:
Publisher Name: Springer, Vienna
Print ISBN: 978-3-211-75717-8
Online ISBN: 978-3-211-75718-5
eBook Packages: MedicineMedicine (R0)